Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
BayFirst Financial Corp Q1 2026 Earnings Call - $80M Capital Raise and New CEO Signal Turnaround Amid SBA 7(a) Losses
BayFirst Financial Corp reported a widened net loss of $5.7 million in Q1 2026, driven by a $2.3 million servicing cost increase on its legacy SBA 7(a) portfolio and higher provision for credit losses...
- BayFirst reported a net loss of $5.7 million in Q1 2026, a significant widening from the $2.8 million loss in Q4 2025.
- The bank secured an $80 million capital raise via a PIPE offering, with convertible preferred shares set to convert at $3.50 per share.
- A rights offering is scheduled for July 14th, allowing existing shareholders to participate in the capital increase.
- +12 more takeaways
First Commonwealth Financial Corporation Q1 2026 Earnings Call - NIM Expansion and Loan Payoff Headwinds
First Commonwealth Financial Corporation reported a Q1 2026 net income of $37.5 million ($0.37 EPS), missing the $0.40 consensus estimate as net interest income contracted by $4.2 million. The decline...
- Net income of $37.5 million ($0.37 EPS) missed the $0.40 consensus estimate, primarily due to a $4.2 million decline in net interest income.
- Net interest income fell to $109.3 million, driven by a $210 million sale of Eastern PA commercial loans and a $150 million year-over-year increase in loan payoffs.
- The net interest margin (NIM) contracted to 3.92% but management raised full-year guidance, projecting the margin to reach the low 4% range by Q4 2026.
- +7 more takeaways
Federated Hermes Q1 2026 Earnings Call - Record AUM Driven by MDT Equity and Money Market Dominance
Federated Hermes delivered a quarter defined by scale and structural momentum, closing Q1 2026 with a record $907 billion in assets under management. The growth was not broad-based but heavily concent...
- Total assets under management hit a record $907 billion, fueled by record equity assets of $101 billion and money market assets reaching $685 billion.
- MDT fundamental quant strategies dominated sales flows, posting record gross equity sales of $9.1 billion and $3.5 billion in net sales for MDT equity and market neutral strategies combined.
- Money market assets grew by $2 billion to $685 billion, with separate accounts surging $8 billion, though mutual fund assets declined $6 billion due to seasonal outflows.
- +7 more takeaways
Vista Gold Corp Q1 2026 Earnings Call - Mount Todd Financing Closes, Detailed Engineering Set for 2027
Vista Gold raised $42 million net in a March equity offering, bringing cash to $52.7 million and clearing the path for Mount Todd project development. Management used the capital to expand its Austral...
- Vista Gold raised $44.85 million gross and $42 million net from a public equity offering in March, providing immediate capital for project advancement.
- Cash on hand increased to $52.7 million from $13.6 million at year-end 2025, with the balance sheet remaining completely debt-free.
- Management confirmed the company is on track to commence detailed engineering and design for the Mount Todd project in 2027.
- +7 more takeaways
Select Medical Holdings Corporation Q1 2026 Earnings Call - Take-Private Deal Nears Close Amid Mixed Earnings and Regulatory Headwinds
Select Medical Holdings delivered a mixed first quarter, with revenue up 5% but adjusted EBITDA falling 6.5% as the Critical Illness Recovery Hospital division struggled with a 15% margin compression....
- Take-Private Deal Nears Closure: The consortium led by Executive Chairman Robert Ortenzio and Welsh, Carson, Anderson & Stowe received unanimous board approval to acquire Select Medical for $16.50 per share. The Hart-Scott-Rodino waiting period expired on April 27, and the transaction is expected to close in mid-2026, subject to remaining regulatory and shareholder approvals.
- Debt Load Increases with Transaction: Contingent on the take-private deal, the company will secure an additional $1 billion in term loan borrowings at SOFR plus 3%. Total debt currently stands at $1.9 billion, with a leverage ratio of 3.75x under senior secured credit agreements.
- Revenue Growth Driven by Inpatient Rehab: Consolidated revenue rose 5% year-over-year, with the Inpatient Rehabilitation Hospital division leading the charge with a 14% revenue increase to $351.9 million. Average daily census grew 12%, and same-store occupancy reached 87%.
- +7 more takeaways
Aon PLC Q1 2026 Earnings Call - Broad-Based Growth Driven by AI and Data Center Demand
Aon delivered a disciplined first quarter, posting 5% organic revenue growth and a 70-basis-point expansion in adjusted operating margins to 39.1%. The results underscore the 3x3 Plan’s core thesis: A...
- Organic revenue grew 5% in Q1 2026, with total revenue reaching $5 billion, in line with mid-single-digit guidance.
- Commercial Risk delivered 7% organic growth for the fourth consecutive quarter, driven by double-digit construction growth and strong M&A activity.
- Data center demand is a structural tailwind, with the construction pipeline running three times higher than the prior year, though it is one component of broad-based growth.
- +7 more takeaways
Materion Corporation Q1 2026 Earnings Call - Record Backlog and AI-Driven Margin Expansion Signal Accelerating Growth
Materion Corporation delivered a record-breaking first quarter of 2026, driven by surging AI demand across its semiconductor, aerospace, and defense end markets. Electronic Materials sales jumped 18% ...
- Materion reported record first-quarter adjusted EBITDA margins of 20.2%, driven by volume growth, favorable price mix, and operational improvements, particularly in Electronic Materials.
- Electronic Materials sales surged 18% year-over-year, fueled by AI-led demand for high-performance memory, data storage, and power applications.
- Precision Optics delivered a 43% year-over-year sales increase, marking its strongest quarter since 2021 and fifth consecutive quarter of profitability improvement.
- +9 more takeaways
Fulgent Genetics 1st Quarter 2026 Earnings Call - Revenue Guidance Reiterated Despite Customer Loss, Margin Pressure, and Aggressive Buybacks
Fulgent Genetics reported a disappointing Q1 2026, with revenue falling to $71.1 million as its largest customer shifted testing in-house and claims processing backlogs lingered. Gross margins compres...
- Revenue fell 14.6% sequentially to $71.1 million, driven by volume decline from the largest customer transitioning testing in-house and timing delays in claims processing.
- Non-GAAP gross margin compressed to 32.3% as fixed costs were spread over a lower revenue base, with management expecting normalization as volumes recover.
- Management reiterated full-year 2026 revenue guidance of $350 million, anticipating that Bako Diagnostics and StrataDX contributions (~$53 million) will offset the largest customer loss in H2.
- +12 more takeaways
Magna International Q1 2026 Earnings Call - Margin Expansion and Cash Flow Surge
Magna International delivered a robust Q1 2026, with sales up 3% year-over-year and adjusted EBIT margin expanding 190 basis points to 5.4%. Adjusted EPS surged 77% to $1.38, driven by strong operatio...
- Q1 2026 sales reached $10.4 billion, up 3% year-over-year, with weighted growth exceeding market by 3%. Excluding foreign currency, sales were down 2%, reflecting a 7% decline in global light vehicle production.
- Adjusted EBIT margin expanded 190 basis points to 5.4%, with adjusted EBIT up 58% to $558 million. Adjusted EPS rose 77% to $1.38, surpassing expectations.
- Free cash flow surged to $372 million, up $685 million from the prior year, driven by $677 million in operating cash flow and improved working capital management.
- +7 more takeaways
Lazard Q1 2026 Earnings Call - Campbell Lutyens Acquisition and Private Capital Advisory Expansion
Lazard delivered a solid first quarter of 2026, with firm-wide adjusted net revenue rising 5% to $673 million. The quarter was defined by the strategic acquisition of Campbell Lutyens, which establish...
- Lazard announced the acquisition of Campbell Lutyens, creating Lazard CL, a new global private capital advisory unit. The deal is expected to close before the end of 2026 and will make Lazard the leading primary and secondary fundraising advisor globally with approximately $500 million in anticipated combined 2027 revenue.
- Firm-wide adjusted net revenue for Q1 2026 was $673 million, up 5% year-over-year, driven by strong performance in asset management and restructuring, which offset a 4% decline in financial advisory revenue.
- Asset management reported $9 billion in net inflows, the highest quarterly net flows in nearly 20 years. Average AUM was $266 billion, up 15% year-over-year, with management fees rising 25% to $296 million.
- +7 more takeaways